Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. 1998

G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA. gcarmona@intra.nida.nih.gov

A primary enzyme for the metabolism of cocaine is butyrylcholinesterase (BChE). To determine whether the systemic administration of BChE can increase the metabolism of cocaine sufficiently to alter a behavioral effect, rats were tested in a locomotor activity chamber after receiving 17 mg of cocaine per kg intraperitoneally. In rats pretreated intravenously with 5,000 IU of horse serum-derived BChE, the locomotor activity effect was significantly attenuated. BChE pretreatment increased plasma BChE levels approximately 400-fold. When added to rat plasma, this amount of BChE reduced the cocaine half-life from over 5 hr to less than 5 min. BChE altered the cocaine metabolic pattern such that the relatively nontoxic metabolite ecgonine methyl ester was produced, rather than benzoylecgonine. These results suggest that systemic administration of BChE can increase the metabolism of cocaine sufficiently to alter a behavioral effect of cocaine and thus should be investigated as a potential treatment for cocaine abuse.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
April 1997, Synapse (New York, N.Y.),
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
January 2014, The American journal on addictions,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
March 2013, Chemico-biological interactions,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
July 1991, Pharmacology, biochemistry, and behavior,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
August 2002, Physiology & behavior,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
January 2020, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
June 2001, Annals of the New York Academy of Sciences,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
August 2013, Neuroscience letters,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
October 2003, Psychopharmacology,
G N Carmona, and C W Schindler, and M Shoaib, and R Jufer, and E J Cone, and S R Goldberg, and N H Greig, and Q S Yu, and D A Gorelick
August 2002, Psychopharmacology,
Copied contents to your clipboard!